1,352 results on '"Mullol, Joaquim"'
Search Results
2. Type 2 and Non-type 2 Inflammation in the Upper Airways: Cellular and Molecular Alterations in Olfactory Neuroepithelium Cell Populations
3. Vasculitis Including Churg–Strauss Syndrome
4. Effects of Endoscopic Sinus Surgery on Olfactory Function
5. Management of Mechanical Nasal Obstruction Isolated or Associated to Upper Airway Inflammatory Diseases in Real Life: Use of both Subjective and Objective Criteria
6. Type 2 chronic inflammatory diseases: targets, therapies and unmet needs
7. Respiratory Exposure Tests in Aspirin Exacerbated Respiratory Disease
8. Consensus on the management of united airways disease with type 2 inflammation: a multidisciplinary Delphi study
9. Poor Rhinitis and Asthma Control Is Associated With Decreased Health-Related Quality of Life and Utilities: A MASK-air Study
10. Pathophysiological Link Between Chronic Rhinosinusitis and Ear Disease
11. Effect of MP-AzeFlu in IL-1 beta-induced IL-6 and proinflammatory cytokines
12. Omalizumab improves sinonasal outcomes in patients with chronic rhinosinusitis with nasal polyps regardless of allergic status
13. The effect of biologics in lung function and quality of life of patients with united airways disease: A systematic review
14. Pheno-Endotyping Antrochoanal Nasal Polyposis
15. Olfactory Dysfunction in Mental Illness
16. Pathophysiology of SARS-CoV-2 Infection of Nasal Respiratory and Olfactory Epithelia and Its Clinical Impact
17. MASK-air: An OECD (Organisation for Economic Co-operation and Development) Best Practice for Public Health on Integrated Care for Chronic Diseases
18. Comparison of Long-term Response and Remission to Omalizumab and Anti-IL-5/IL-5R Using Different Criteria in a Real-life Cohort of Severe Asthma Patients
19. Disposition of Work-Related Asthma in a Spanish Asthma Cohort: Comparison of Asthma Severity Between Employed and Retired Workers
20. The Unified Airway Hypothesis: Evidence From Specific Intervention With Anti–IL-5 Biologic Therapy
21. Dupilumab efficacy across serum IgE and blood eosinophil levels in chronic rhinosinusitis with nasal polyposis
22. Current Management of Allergic Rhinitis
23. Atopic dermatitis in pediatric population from Catalonia: A retrospective, large‐scale population‐based study
24. Cutoff Values of MASK-air Patient-Reported Outcome Measures
25. Identification of Asthma Phenotypes in the Spanish MEGA Cohort Study Using Cluster Analysis
26. Mechanisms by which dupilumab normalizes eicosanoid metabolism and restores aspirin-tolerance in AERD: A hypothesis
27. Chronic Rhinosinusitis Outcome Registry (CHRINOSOR): Establishment of an International Outcome Registry Driven by mHealth Technology
28. Quality of Life Quality of life (QoL) and Psychological Burden
29. Multimorbidities
30. Olfactory Function Assessment
31. Alpha-1 antitrypsin deficiency and Pi*S and Pi*Z SERPINA1 variants are associated with asthma exacerbations
32. A Decade of Clinical Advances in Chronic Rhinosinusitis: 2012–2022
33. Academic Productivity of Young People With Allergic Rhinitis: A MASK-air Study
34. The Allergic Rhinitis and Its Impact on Asthma (ARIA) Approach of Value-Added Medicines: As-Needed Treatment in Allergic Rhinitis
35. Poor rhinitis and asthma control is associated with decreased health-related quality-of-life and utilities: A MASK-air study
36. MASK-air®: An OECD (Organisation for Economic Coordination and Development) Best Practice for Public Health on integrated care for chronic diseases.
37. Impact of Mepolizumab on Sleep Disturbance in Patients With Chronic Rhinosinusitis With Nasal Polyps and/or Asthma: Analysis From SYNAPSE and MUSCA
38. Olfactory Bulb Excitotoxicity as a Gap-Filling Mechanism Underlying the Link Between Traumatic Brain Injury-Induced Secondary Neuronal Degeneration and Parkinson’s Disease-Like Pathology
39. Management of United Airway Disease Focused on Patients With Asthma and Chronic Rhinosinusitis With Nasal Polyps: A Systematic Review
40. Chronic Rhinosinusitis With Nasal Polyps: Quality of Life in the Biologics Era
41. Chronic Rhinosinusitis and COVID-19
42. Olfactory Outcomes With Dupilumab in Chronic Rhinosinusitis With Nasal Polyps
43. Is the Nasal Cycle Real? How Important Is It?
44. Omalizumab improves sleep and health status for patients with chronic rhinosinusitis with nasal polyps: An analysis of randomized clinical trials.
45. Prevalence and coexistence of type 2 inflammatory diseases.
46. International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis
47. Quality of Life and Psychological Burden
48. Epidemiology of Allergic Rhinitis
49. EUFOREA/EPOS2020 statement on the clinical considerations for CRSwNP care
50. Upregulation of Platelet-Activating Factor Receptor Expression and Lyso-Platelet-Activating Factor Isoforms in Human Nasal Polyp Tissues
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.